Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,368,764 papers from all fields of science
Search
Sign In
Create Free Account
PCP2 gene
Known as:
PCP2
, GPSM4
, MGC41903
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
PCP4 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Genetic basis of relapsing polychondritis revealed by family‐based whole‐exome sequencing
Junmei Feng
,
Xiao-Yu Zuo
,
+8 authors
Zhiming Lin
International Journal of Rheumatic Diseases
2020
Corpus ID: 211557612
Genetic factors are believed to be implicated in the pathogenesis of relapsing polychondritis (RP). However, the molecular…
Expand
Review
2018
Review
2018
AB0022 Family-based whole-exome sequencing reveals the genetic basis of relapsing polychondritis
Z. Lin
,
L. Gui
,
+6 authors
J. Gu
Genomics, genetic basis of disease and antigen…
2018
Corpus ID: 81965710
Background Relapsing polychondritis (RP) is a rare systemic disease, characterised by recurrent episodes of inflammation of…
Expand
2016
2016
Expression of a novel splicing variant of Pcp2 in closely related laboratory rodents.
M. Przybyła
,
M. Nowacka-Chmielewska
,
Jarosław J. Barski
Genetics and Molecular Research
2016
Corpus ID: 6786515
Purkinje cell protein-2 (PCP2), also known as L7, is a member of the GoLoco protein family with highly cell-specific expression…
Expand
2002
2002
Association and colocalization of G protein α subunits and Purkinje cell protein 2 (Pcp2) in mammalian cerebellum
K. Redd
,
J. Oberdick
,
J. Mccoy
,
B. Denker
,
Yuan Luo
Journal of Neuroscience Research
2002
Corpus ID: 28174954
Previously, we have demonstrated a novel interaction between Gαo protein and Purkinje cell protein‐2 (Pcp2, also known as L7) in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE